全球最大的一些科技公司紛紛涉足發債發股進行融資，來支撐人工智能基礎設施建設，硅谷企業均一改以往依靠自有現金進行投資的傳統模式。Alphabet、亞馬遜、微軟和Meta都表示，AI支出不會放緩。科技巨頭今年的合計支出預計將超過7000億美元，高於此前預期的約6000億美元。橋水基金2月的分析指出，AI熱潮已進入更危險的階段，實物基礎設施投資呈指數級增長，企業對外部資本的依賴也日益加深。

July 7 — Naohu Technology’s implantable brain–computer interface (BCI) hand motor-function compensation system, described as fully implanted, fully wireless and full-function, began a GCP registration clinical trial at Fudan University‑affiliated Huashan Hospital. The multicenter GCP trial will be run with 15 tertiary hospitals in Shanghai and other regions to evaluate safety and efficacy for compensating upper‑limb function in patients with tetraplegia from cervical spinal cord injury. The device is the first subdural cortical‑surface implantable BCI to enter China’s national Class III medical device registration clinical stage, marking a key step toward scaled clinical application of BCI technology in China.

Rivian(RIVN.O)在計劃出售股票後，股價幅度擴大至15%，創自2024年11月以來最大跌幅。